LOS ANGELES, May 30, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB:
MDBX) (www.medbox.com), a leader in providing ancillary services to
the alternative medicine industry, dispensary consulting services,
and patented medicine dispensing systems to medical and retail
industries, commented today on the news that the U.S. House of
Representatives voted to effectively end DEA intervention in legal
medical marijuana operations.
The House passed the amendment late Thursday night, which
restricts the Drug Enforcement Administration from targeting
medical marijuana operations in states where it is legal.
The 219-189 decision came on a bipartisan appropriations
amendment spearheaded by California Republican Rep. Dana Rohrabacher and California Democrat Sam Farr.
Rep. Earl Blumenauer, Democrat
from Oregon, stated, "The
conflicting nature of state and federal marijuana laws has created
an untenable situation," according to the Huffington Post. "It's
time we take the federal government out of the equation so medical
marijuana business owners operating under state law aren't living
in constant fear of having their doors kicked down in the middle of
the night."
"We are pleased that the United
States House of Representatives has voted to end federal
interference with dispensary operations in those states where these
activities are considered legal," said Dr. Bruce Bedrick, Chief Executive Officer of
Medbox, Inc. "As the industry's leading proponent of sensible
cannabis regulations, we are gratified to see that federal
lawmakers now accept that individual states' regulatory agencies
are best equipped to manage their own cannabis industries. We
believe this is a big step forward for dispensary operators and
those who provide products and services to this growing
market."
Currently 22 states and the District
of Columbia allow marijuana use for medicinal purposes. Five
others don't allow smoking of the plant, but do allow CBD oil – an
ingredient in marijuana that may treat epilepsy.
About Medbox, Inc.
Medbox is a leader in the development, sales and service of
automated, biometrically controlled dispensing and storage systems
for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned
subsidiary, Medicine Dispensing Systems, offers their patented
systems, software and consulting services to pharmacies,
alternative medicine dispensaries and local governments in the U.S.
In addition, through its wholly owned subsidiary, Vaporfection
International, Inc. (www.vaporfection.com), the company offers an
industry award winning medical vaporizer product. Medbox, through
its newly established subsidiaries, is in development of the
following ancillary services catered to the alternative medicine
industry: merchant services and armored transport for cash
deposits, cannabidiol research and development, real estate
acquisitions and subsequent lease programs to alternative medicine
dispensaries, and alternative medicine dispensary management
services.
For more information on Medbox, please contact (800) 762-1452 or
go online to: http://www.medbox.com.
Forward-Looking Statements
The statements in this
press release constitute forward-looking statements within the
meaning of federal securities laws. Such statements are based on
our current beliefs and expectations and are inherently subject to
significant business, economic and competitive uncertainties and
contingencies, many of which are beyond our control. In addition,
such forward-looking statements are subject to assumptions with
respect to future business strategies and decisions that are
subject to change. Potential risks and uncertainties include, but
are not limited to, technical advances in the industry as well as
political and economic conditions present within the industry. We
do not take any obligation to update any forward-looking statement
to reflect events or developments after a forward-looking statement
was made.
Contact Information
Investor Relations:
Stephen Hart
Hayden IR
hart@haydenir.com
917-658-7878
SOURCE Medbox, Inc.